430 related articles for article (PubMed ID: 21784389)
1. Relation of growth-differentiation factor 15 to left ventricular remodeling in ST-segment elevation myocardial infarction.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P
Am J Cardiol; 2011 Oct; 108(7):955-8. PubMed ID: 21784389
[TBL] [Abstract][Full Text] [Related]
2. Plasma osteoprotegerin level on admission is associated with no-reflow phenomenon after primary angioplasty and subsequent left ventricular remodeling in patients with acute ST-segment elevation myocardial infarction.
Erkol A; Oduncu V; Pala S; Kızılırmak F; Kılıcgedik A; Yılmaz F; Güler A; Karabay CY; Kırma C
Atherosclerosis; 2012 Mar; 221(1):254-9. PubMed ID: 22265272
[TBL] [Abstract][Full Text] [Related]
3. Prognostic Value of Speckle Tracking Echocardiography in Patients with ST-Elevation Myocardial Infarction Treated with Late Percutaneous Intervention.
Cong T; Sun Y; Shang Z; Wang K; Su D; Zhong L; Zhang S; Yang Y
Echocardiography; 2015 Sep; 32(9):1384-91. PubMed ID: 25471825
[TBL] [Abstract][Full Text] [Related]
4. Value of speckle-tracking echocardiography for prediction of left ventricular remodeling in patients with ST-elevation myocardial infarction treated by primary percutaneous intervention.
Bochenek T; Wita K; Tabor Z; Grabka M; Krzych Ł; Wróbel W; Berger-Kucza A; Elżbieciak M; Doruchowska A; Gluza MT
J Am Soc Echocardiogr; 2011 Dec; 24(12):1342-8. PubMed ID: 22000785
[TBL] [Abstract][Full Text] [Related]
5. Neopterin predicts left ventricular remodeling in patients with ST-segment elevation myocardial infarction undergoing primary percutaneous coronary intervention.
Dominguez-Rodriguez A; Abreu-Gonzalez P; Avanzas P; Laynez-Cerdeña I; Kaski JC
Atherosclerosis; 2010 Aug; 211(2):574-8. PubMed ID: 20451908
[TBL] [Abstract][Full Text] [Related]
6. Prognostic value of different serum biomarkers for left ventricular remodelling after ST-elevation myocardial infarction treated with primary percutaneous coronary intervention.
Urbano-Moral JA; Lopez-Haldon JE; Fernandez M; Mancha F; Sanchez A; Rodriguez-Puras MJ; Villa M; Lopez-Pardo F; Diaz de la Llera L; Valle JI; Martinez A
Heart; 2012 Aug; 98(15):1153-9. PubMed ID: 22572051
[TBL] [Abstract][Full Text] [Related]
7. Low adiponectin blood concentration predicts left ventricular remodeling after ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention.
Piestrzeniewicz K; Luczak K; Maciejewski M; Drozdz J
Cardiol J; 2010; 17(1):49-56. PubMed ID: 20104457
[TBL] [Abstract][Full Text] [Related]
8. Growth-differentiation factor-15 and major cardiac events.
Lin JF; Wu S; Hsu SY; Yeh KH; Chou HH; Cheng ST; Wu TY; Hsu WT; Yang CC; Ko YL
Am J Med Sci; 2014 Apr; 347(4):305-11. PubMed ID: 24521768
[TBL] [Abstract][Full Text] [Related]
9. Novel role of platelet reactivity in adverse left ventricular remodelling after ST-segment elevation myocardial infarction: The REMODELING Trial.
Park Y; Tantry US; Koh JS; Ahn JH; Kang MG; Kim KH; Jang JY; Park HW; Park JR; Hwang SJ; Park KS; Kwak CH; Hwang JY; Gurbel PA; Jeong YH
Thromb Haemost; 2017 May; 117(5):911-922. PubMed ID: 28150852
[TBL] [Abstract][Full Text] [Related]
10. Heart rate and left ventricular adverse remodelling after ST-elevation myocardial infarction.
Reindl M; Reinstadler SJ; Feistritzer HJ; Tiller C; Mayr A; Klug G; Metzler B
Int J Cardiol; 2016 Sep; 219():339-44. PubMed ID: 27348414
[TBL] [Abstract][Full Text] [Related]
11. GDF-15 and TRAIL-R2 are powerful predictors of long-term mortality in patients with acute myocardial infarction.
Skau E; Henriksen E; Wagner P; Hedberg P; Siegbahn A; Leppert J
Eur J Prev Cardiol; 2017 Oct; 24(15):1576-1583. PubMed ID: 28762762
[TBL] [Abstract][Full Text] [Related]
12. Non-invasive coronary flow reserve after successful primary angioplasty for acute anterior myocardial infarction is an independent predictor of left ventricular adverse remodelling.
Meimoun P; Boulanger J; Luycx-Bore A; Zemir H; Elmkies F; Malaquin D; Doutrelan L; Tribouilloy C
Eur J Echocardiogr; 2010 Sep; 11(8):711-8. PubMed ID: 20378685
[TBL] [Abstract][Full Text] [Related]
13. Association of Angiotensin II Receptor Type 1 and Endothelin-1 Receptor Type A Agonistic Autoantibodies With Adverse Remodeling and Cardiovascular Events After Acute Myocardial Infarction.
Tona F; Civieri G; Vadori M; Masiero G; Iop L; Marra MP; Perin V; Cuciz E; Cecere A; Bernava G; Tansella D; Naumova N; Grewal S; Cozzi E; Iliceto S
J Am Heart Assoc; 2024 Feb; 13(4):e032672. PubMed ID: 38348777
[TBL] [Abstract][Full Text] [Related]
14. Predictive value of ischemic mitral regurgitation during the acute phase of ST elevation myocardial infarction treated with primary coronary intervention for left ventricular remodeling in long-term follow-up.
Wita K; Berger-Kucza A; Filipecki A; Turski M; Bochenek T; Wróbel W; Lelek M; Weglarz P; Elzbieciak M; Trusz-Gluza M
Coron Artery Dis; 2010 Sep; 21(6):325-9. PubMed ID: 20453641
[TBL] [Abstract][Full Text] [Related]
15. Relation of plasma brain natriuretic peptide levels on admission for ST-elevation myocardial infarction to left ventricular end-diastolic volume six months later measured by both echocardiography and cardiac magnetic resonance.
Garcia-Alvarez A; Sitges M; Delgado V; Ortiz J; Vidal B; Poyatos S; de Caralt TM; Heras M; Bosch X; Azqueta M; Pare C; Brugada J
Am J Cardiol; 2009 Oct; 104(7):878-82. PubMed ID: 19766750
[TBL] [Abstract][Full Text] [Related]
16. Reverse Left Ventricular Remodelling in ST-Elevation Myocardial Infarction Patients Undergoing Primary Percutaneous Coronary Intervention: Incidence, Predictors, and Impact on Outcome.
Choe JC; Cha KS; Yun EY; Ahn J; Park JS; Lee HW; Oh JH; Kim JS; Choi JH; Park YH; Lee HC; Kim JH; Chun KJ; Hong TJ; Ahn Y; Jeong MH; Chae SC; Kim YJ;
Heart Lung Circ; 2018 Feb; 27(2):154-164. PubMed ID: 28487063
[TBL] [Abstract][Full Text] [Related]
17. Value of brain natriuretic peptide after acute myocardial infarction.
Güneş Y; Okçün B; Kavlak E; Erbaş C; Karcier S
Anadolu Kardiyol Derg; 2008 Jun; 8(3):182-7. PubMed ID: 18524723
[TBL] [Abstract][Full Text] [Related]
18. Galectin-3 predicts left ventricular remodelling after anterior-wall myocardial infarction treated by primary percutaneous coronary intervention.
Di Tano G; Caretta G; De Maria R; Parolini M; Bassi L; Testa S; Pirelli S
Heart; 2017 Jan; 103(1):71-77. PubMed ID: 27465055
[TBL] [Abstract][Full Text] [Related]
19. Circulating levels of hepatocyte growth factor and left ventricular remodelling after acute myocardial infarction (from the REVE-2 study).
Lamblin N; Bauters A; Fertin M; de Groote P; Pinet F; Bauters C
Eur J Heart Fail; 2011 Dec; 13(12):1314-22. PubMed ID: 21996026
[TBL] [Abstract][Full Text] [Related]
20. Usefulness of satisfactory control of low-density lipoprotein cholesterol to predict left ventricular remodeling after a first ST-elevation myocardial infarction successfully reperfused.
Buono F; Spinelli L; Giallauria F; Assante di Panzillo E; Di Marino S; Ferrara F; Vigorito C; Trimarco B; Morisco C
Am J Cardiol; 2011 Jun; 107(12):1772-8. PubMed ID: 21529724
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
